PET partners target new centers

Article

InHealth Group and CTI have agreed to jointly develop seven new PET and PET/CT centers in the U.K. and to collaborate in the management of existing InHealth imaging centers to provide PET and PET/CT services. Onsite manufacturing facilities using CTI

InHealth Group and CTI have agreed to jointly develop seven new PET and PET/CT centers in the U.K. and to collaborate in the management of existing InHealth imaging centers to provide PET and PET/CT services. Onsite manufacturing facilities using CTI technology will produce positron radioisotopes, including FDG. The new centers will be established in close collaboration with the U.K.'s major National Health Service trusts and leading academic institutions. Additionally, the two companies will support a U.K.-wide mobile scanning service. Both the mobile service and the first scanning center are already operational, and InHealth has already carried out more than 2000 PET scans. InHealth will utilize CTI's cyclotron and chemistry technology and expertise in the development of new PET tracer production, pharmacy, and distribution facilities.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.